Beyfortus shortage — CH supply status & alternatives

Beyfortus

ATC J06BD08

🇦🇺 AUST R 397898 · Sanofi-Aventis Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇭 CH

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Beyfortus
ATC level 5	J06BD08
ATC level 4	J06BD
Therapeutic category	Auto-created by Swissmedic scraper
Controlled substance	No

Marketing-authorisation holders	Sanofi-Aventis Australia Pty Ltd, Sanofi Pasteur Inc., Sanofi Winthrop Industrie, SANOFI VACCINES CANADA LTD.

Registrations on file	5

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Verified timeline regulator events

🇨🇭 1 July 2026

medium reported

🇨🇭 28 June 2026

medium reported

🇨🇭 27 June 2026

medium reported

🇨🇭 26 June 2026

medium reported

🇨🇭 22 June 2026

medium reported

🇨🇭 21 June 2026

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders5 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
BEYFORTUS nirsevimab	50mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
BEYFORTUS nirsevimab	100mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
BEYFORTUS	100mg/mL	injection	🇺🇸 US	Sanofi Pasteur Inc.	Active
Beyfortus	—	—	🌐 EU	Sanofi Winthrop Industrie	Active
BEYFORTUS	—	solution	🇨🇦 CA	SANOFI VACCINES CANADA LTD.	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.